Anaptysbio (ANAB) Shares Outstanding (Diluted Average) (2016 - 2026)

Anaptysbio (ANAB) has 10 years of Shares Outstanding (Diluted Average) data on file, last reported at $28.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 6.37% year-over-year to $28.7 million; the trailing twelve-month figure through Mar 2026 stood at $28.7 million (down 6.37% YoY), and the FY2025 full-year result was $28.8 million, up 1.32% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $28.7 million, roughly flat from $28.8 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $30.6 million in Q1 2025 and bottomed at $26.5 million in Q3 2023.
• The 5-year median for Shares Outstanding (Diluted Average) is $28.0 million (2022), against an average of $28.0 million.
• The widest annual swing landed in 2025, when Shares Outstanding (Diluted Average) increased 14.34%; it then fell 6.37% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $28.2 million in 2022, then decreased by 4.41% to $26.9 million in 2023, then climbed by 5.42% to $28.4 million in 2024, then grew by 1.32% to $28.8 million in 2025, then slipped by 0.23% to $28.7 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $28.7 million (Q1 2026), $28.8 million (Q4 2025), and $29.0 million (Q3 2025), per Business Quant data.

Peer Comparison